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Abstract: Leukotrienes (LT) and prostaglandins
(PG) are proinflammatory mediators generated by
the conversion of arachidonic acid via 5-lipoxygen-
ase (5-LO) and cyclooxygenase (COX) pathways. It
has long been proposed that the inhibition of the
5-LO could enhance the COX pathway leading to
an increased PG generation. We have found that in
in vitro models of inflammation, such as mice-elic-
ited peritoneal macrophages activated with lipo-
polysaccharide (LPS)/interferon- (IFN-), the de-
letion of the gene encoding for 5-LO or the enzyme
activity inhibition corresponded to a negative mod-
ulation of the COX pathway. Moreover, exog-
enously added LTC4, but not LTD4, LTE4, and
LTB4, was able to increase PG production in stim-
ulated cells from 5-LO wild-type and knockout
mice. LTC4 was not able to induce COX-2 expres-
sion by itself but rather potentiated the action of
LPS/IFN- through the extracellular signal-regu-
lated kinase-1/2 activation, as demonstrated by the
use of a specific mitogen-activated protein kinase
(MAPK) kinase inhibitor. The LT-induced increase
in PG generation, as well as MAPK activation, was
dependent by a specific ligand-receptor interac-
tion, as demonstrated by the use of a cys-LT1
receptor antagonist, although also a direct action
of the antagonist used, on PG generation, cannot
be excluded. Thus, the balance between COX and
5-LO metabolites could be of great importance in
controlling macrophage functions and conse-
quently, inflammation and tumor promotion. J.
Leukoc. Biol. 78: 985–991; 2005.
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INTRODUCTION
The leukotrienes (LT), LTB4 and cysteinyl LT (cys-LT; LTC4,
LTD4, and LTE4), are metabolic products of arachidonic acid
(AA) via the 5-lipoxygenase (5-LO) pathway [1]. The biologic
activities of LT suggest that they are mediators of acute in-
flammatory and immediate hypersensitivity responses. The
cys-LT and LTB4 increase the adhesion of leukocytes to en-
dothelial cells [2]; LTC4 causes contraction of endothelial
cells, resulting in increased permeability of postcapillary
venules, and LTB4 is a potent chemotactic factor for neutro-
phils [3]. Moreover, they seem to be involved in the regulation
of inflammatory cell functions, such as macrophages. These
cells, as a result of their phagocytosing and secretory functions,
are important effector cells and because of their interaction
with lymphocytes, are also involved in the surveillance of the
immune system cells [4] and play a role in host defense against
tumor cells. Moreover, macrophages are a major component of
the leukocyte infiltrate of tumors. Tumor-associated macro-
phages have a complex, dual function in their interactions with
neoplastic cells, and experimental evidences suggest that they
are part of inflammatory circuits that promote tumor progres-
sion [5, 6]. Activated macrophages express many bioactive
molecules, including eicosanoids [LT and prostaglandins (PG)]
[7]. The biosynthesis of prostanoids and LT depends on AA
availability, as AA is the common substrate. It has long been
proposed that the inhibition of the 5-LO pathway could en-
hance the cyclooxygenase (COX) pathway leading to an in-
creased PG generation. This is of particular interest, as the
concentration of PG, especially PGE2, is increased in inflam-
mation as well as in different tumor types [8, 9]. However,
contrasting results have been reported. In fact, some reports
failed to show this hypothetical AA shunt [10, 11]. Conversely,
it has been shown that the metabolic products of the COX
pathway, especially PGE2, inhibit LT biosynthesis by neutro-
phils [12].
Thus, the comprehension of the mutual regulation of these
proinflammatory mediators seems to be of particular impor-
tance in the evolution of acute to chronic inflammation and in
the involvement of the latter in tumor development and pro-
gression.
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The aim of this study was to investigate the role of 5-LO in
PG production by the use of 5-LO knockout (5-LOKO) mice
and the correspondent littermate in in vitro models of inflam-
mation, such as elicited mice peritoneal macrophages activated
with lipopolysaccharide (LPS)/interferon- (IFN-).
MATERIALS AND METHODS
Materials
LTC4, LTD4, LTE4, and LTB4 were obtained from SPIBIO (Paris, France). The
PGE2 antibody was a gift from Prof. Giovanni Ciabattoni (University of Chieti,
Italy), and cys-LT antibody was obtained from Sigma-Aldrich (Milan, Italy).
[3H-PGE2], [
3H-6-keto-PGF1], and [
3H-LTC4] were from PerkinElmer Life
Sciences (Milan, Italy). Zileuton was obtained from Sequoia Research Products
(Oxford, UK). All other reagents and compounds used were obtained from
Sigma-Aldrich. Stock solutions of test compounds (zileuton, LTB4, LTC4,
LTD4, LTE4, ICI204.219, and PD98059) were prepared in ethanol; an equiv-
alent amount of ethanol was included in control samples.
Animals
Mice with a targeted disruption of the 5-lipoxygenase gene (5-LOKO) and
littermate wild-type controls (5-LOWT) were purchased from Jackson Labora-
tories (Harlan Nossan, Italy). All mice used for studies were male, 4–5 weeks
old, weighing 20–22 g. The animals were housed in a controlled environment
and provided with standard rodent chow and water. Animal care was in
compliance with Italian regulations regarding protection of animals used for
experimental and other scientific purposes (D.M. 116192) as well as with the
European Economic Community regulations (O.J. of E.C. L 358/1 12/18/1986).
Peritoneal macrophages
Peritoneal macrophages were elicited by intraperitoneal (i.p.) injection of 2 ml
4% sterile thioglycolate (TG) medium (Sigma-Aldrich). After 3 days, mice were
killed, and macrophages were harvested as described [13]. The peritoneal
macrophages were grown in Dulbecco’s modified Eagle’s medium, supple-
mented with 2 mM glutamine, 25 mM Hepes, penicillin (100 U/ml), strepto-
mycin (100 g/ml), 10% fetal bovine serum (FBS), and 1.2% sodium pyruvate
(BioWhittaker, Europe). Cells were plated on tissue-culture plates for 3 h, and
then, nonadherent cells were removed by washing with sterile phosphate-
buffered saline (PBS). Immediately before the experiments, culture medium
was replaced by fresh medium without FBS to avoid interference with radio-
immunoassay (RIA) [14]. The peritoneal macrophages were treated with var-
ious concentrations of LPS Escherichia coli (Serotype 0111:B4) and IFN- in
the presence or absence of test compounds. Incubation media were used for
eicosanoid measurements by RIA. Quantification of the cys-LT was performed
by the use of RIA from Sigma-Aldrich, whereas PGE2 and 6-keto-PGF1 were
quantified as described previously [15]. The levels of prostanoids and cys-LT
were expressed as ng/ml. Cells were used for Western blot analysis.
Mitochondrial respiration
Cell respiration was assessed by the mithochondrial-dependent reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to
formazan [16]. After stimulation with LPS/IFN- in the absence or presence of
the 5-LO inhibitor for 24 h, cells in 96-well plates were incubated with MTT
(0.2 mg/ml) for 1 h. Culture medium was removed by aspiration, and the cells
were solubilized in dimethyl sulfoxide (0.1 ml). The extent of reduction of MTT
to formazan within cells was quantitated by the measurement of optical density
at 550 m.
Western blot analysis
Cells were washed in cold PBS and lysed for 10 min at 4°C with 1 ml lysis
buffer [50 mM Tris, pH 7.4, 0.5% Nonidet P-40, 0.01% sodium dodecyl sulfate
(SDS)] containing complete protease inhibitor cocktail (Roche, Mannheim,
Germany). Lysates from adherent cells were collected by scraping and centri-
fuged at 12,000 g for 15 min at 4°C. The supernatants were collected, and
protein concentration in cell lysates was determined by Bio-Rad protein assay
(Bio-Rad, Richmond CA), and 70 g total protein from each sample was
analyzed. Proteins were separated by a 12% SDS-polyacrylamide gel electro-
phoresis (PAGE) and transferred on nitro-cellulose membrane [Hybond en-
hanced chemiluminescence (ECL) nitrocellulose, Amsherman, Rainham, UK].
The membrane was blocked with 0.1% Tris-buffered saline-Tween containing
5% nonfat milk for 1 h at room temperature. After the blocking, the membranes
were incubated with the relative primary antibody overnight at 4°C. Mouse
monoclonal antibodies anti-phosphorylated extracellular signal-regulated pro-
tein kianse (pERK)-1/2 and anti-ERK-2 were diluted, 1:1000 in 0.1% PBS-
Tween, 0.5% bovine serum albumin (BSA; Santa Cruz Biotechnology, CA),
whereas rabbit polyclonal antibodies anti-pAKT and anti-AKT (Cell Signaling
Technology Inc., Beverly, MA) were diluted 1:2000. Rabbit polyclonal anti-
body anti-COX-2 and mouse monoclonal tubulin (Santa Cruz Biotechnology)
antibody were diluted 1:1000 in 0.1% PBS-Tween, 5% BSA. After the incu-
bation, the membranes were washed six times with 0.1% PBS-Tween and were
incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit
secondary antibodies (Bio-Rad), diluted 1:2000 in 0.2% PBS-Tween; the
membranes were washed; and protein bands were detected by an ECL system
(Amersham Pharmacia, Little Chalfont, UK). Densitometric analysis was per-
formed with a Fluor S quantitative imaging system (Bio-Rad).
Statistical analysis
The results are expressed as mean  SEM of n observations, where n represents
the number of experiments performed in different days. Triplicate wells were
used for the various treatment conditions. The results were analyzed by
one-way ANOVA followed by a Bonferroni post-hoc test for multiple compar-
isons. A P value less than 0.05 was considered significant.
RESULTS
PG production by peritoneal macrophages from
5-LOKO and 5-LOWT mice
To verify if the deletion of the 5-LO gene or enzyme inhibition
could affect PG generation in elicited peritoneal macrophages
activated with LPS/IFN-, we incubated the cells from
5-LOWT and 5-LOKO mice with LPS (0.1 g/ml) and IFN- (1
U/ml) for 24 h. Unstimulated peritoneal macrophages from
5-LOWT or 5-LOKO mice produced only small amounts, not
significantly different, of PGE2 and 6-keto-PGF1. Activation
of the cells with LPS (0.1 g/ml) and IFN- (1 U/ml) for 24 h
significantly increased PGE2 and 6-keto-PGF1 (P0.001)
production in peritoneal macrophages from 5-LOWT and
5-LOKO mice. However, the increase observed in 5-LOKO
animals was significantly (P0.001) lower for PGE2 and 6-ke-
to-PGF1 with respect to what was observed in macrophages
from 5-LOWT mice (Fig. 1, A and B). In the incubation media
of the cells from WT animals, we could only detect cys-LTs and
not LTB4 by the unstimulated and stimulated cells. The release
of cys-LT was detectable only at 18 and 24 h (0.380.05 and
0.330.06 ng/ml, respectively); in fact, at 2 and 4 h the
release was below the detection limit of the assay (0.078
ng/ml). The LT production from unstimulated and stimulated
cells from 5-LOKO animals was undetectable.
As 5-LO gene deletion decreased PG generation, we inves-
tigated if the inhibition of the enzyme activity produced similar
results. To this aim, we measured PGE2 and 6-keto-PGF1
production by elicited peritoneal macrophages from 5-LOWT
mice activated with LPS (0.1 g/ml) and IFN- (1 U/ml) for
24 h in the absence or presence of the 5-LO inhibitor zileuton.
Similarly to what was observed with 5-LO gene deletion, the
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inhibition of enzyme activity by 30 M of the well-known 5-LO
inhibitor, zileuton, significantly decreased PGE2 and 6-keto-
PGF1 generation (P0.001). However, the inhibition ob-
served in the presence of the 5-LO inhibitor was more pro-
nounced with respect to what was observed following gene
deletion. In fact, at 100 M zileuton, which completely re-
duced cys-LT biosynthesis by 98%, the observed inhibition
was 93% and 85% for PGE2 and 6-keto-PGF1, respectively
(Fig. 2, A and B). The inhibition was not correlated to a toxic
effect of the compound, as demonstrated by cell viability (data
not shown).
Effect of exogenous LTC4 on PG production by
peritoneal macrophages
In the light of the above reported results, we tested the effect
of increasing concentration of exogenous LTC4 (0.001–1 M)
on PGE2 and 6-keto-PGF1 generation by elicited peritoneal
macrophages from 5-LOWT mice activated with LPS (0.1 g/
ml) plus IFN- (1 U/ml) for 24 h. LTC4 (1 M) was unable to
affect PGE2 and 6-keto-PGF1 production by unstimulated
cells (0.390.003 ng/ml, 0.090.001 ng/ml and 0.320.02
ng/ml, and 0.10.01 ng/ml in the absence or presence of
LTC4, respectively), whereas LTC4 concentration dependently
increased PGE2 and 6-keto-PGF1 biosynthesis in stimulated
cells from 5-LOWT mice (Fig. 3, A and B). The described
action of LTC4 was also observed in 5-LOKO mice. In fact,
exogenously added LTC4 (1 M) induced an increase in pro-
stanoid production by stimulated cells of the same extent
observed in WT animals (seven to eight times). The cys-LT1
receptor antagonist ICI 204.219 completely reversed the action
of LTC4 in 5-LOWT and 5-LOKO mice (Fig. 4, A and B),
although a direct action of the antagonist on PG generation
cannot be excluded (data not shown). It is interesting that the
action of the exogenous LTC4 in WT animals was dependent on
the effect of the stimulus used. In fact, at the concentration of
LPS (0.1 g/ml) plus IFN- (1 U/ml), the exogenously added
LTC4 (1 M) induced an increase in PGE2 and 6-keto-PGF1
production of eight to nine and six times, respectively (Fig. 4,
A and B); at LPS (10 g/ml) plus IFN- (100 U/ml), of
approximately three and two times, respectively (Fig. 5, A and
B); and finally, no effect was observed at LPS (100 g/ml) plus
IFN- (1000 U/ml; Fig. 5, A and B). LTB4, LTD4, and LTE4
did not produce any effect (data not shown).
Effect of exogenous LTC4 on activation of
mitogen-activated protein kinase (MAPK) signal
transduction pathway and COX-2 expression in
peritoneal macrophages from 5-LOWT mice
To investigate whether the increase in prostanoid production,
observed in our experimental conditions, corresponded to an
Fig. 1. PG production by peritoneal macrophages
from 5-LOKO and 5-LOWT mice. Peritoneal mac-
rophages were elicited by i.p. injection of 2 ml 4%
sterile TG medium. After 3 days, mice were killed,
and macrophages were harvested. Cells were plated
on 24-multi-well plates for 3 h, and nonadherent
cells were removed by washing with sterile PBS.
Immediately before the experiments, culture me-
dium was replaced by fresh medium without FBS to
avoid interference with RIA. Peritoneal macro-
phages from 5-LOWT and 5-LOKO mice were
treated subsequently for 24 h with LPS (0.1 g/ml)
and IFN- (1 U/ml). PGE2 (A) and 6-keto-PGF1
(B) levels were quantified in medium from cell
incubation without prior extraction or purification by RIA. Data are expressed as means  SEM from three separate experiments performed in triplicate. *, P 
0.001, versus unstimulated cells; , P  0.001, versus 5-LOWT LPS/IFN-.
Fig. 2. Effect of zileuton on PG production by peritoneal macrophages from 5-LOWT mice. Peritoneal macrophages were elicited by i.p. injection of 2 ml 4%
sterile TG medium. After 3 days, mice were killed, and macrophages were harvested. Cells were plated on 24-multi-well plates for 3 h, and nonadherent cells were
removed by washing with sterile PBS. Immediately before the experiments, culture medium was replaced by fresh medium without FBS to avoid interference with
RIA. Peritoneal macrophages from 5-LOWT were treated subsequently for 24 h with LPS (0.1 g/ml) and IFN- (1 U/ml) in the absence or presence of the 5-LO
inhibitor zileuton (30–100 M). PGE2 (A) and 6-keto-PGF1 (B) levels were quantified in medium from cell incubation without prior extraction or purification by
RIA. Data are expressed as means  SEM from three separate experiments performed in triplicate. *, P  0.001, versus unstimulated cells; , P  0.001, versus
5-LOWT LPS/IFN-.
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activation of signal transduction pathways involved in the
regulation of COX-2 expression, we analyzed the activation of
phosphatidylinositol-3 kinase (PI-3K) and MAPK pathways
after 24 h treatment with LPS (0.1 g/ml)/IFN- (1 U/ml) in
the presence or absence of 1 M LTC4. As shown in Figure
6A, stimulation of the cells in the presence of LTC4 induced an
activation of the MAPK pathway of approximately two times
over the basal activation induced by LPS/IFN- only. The
basal and the LTC4-induced MAPK activation were abolished
completely in the presence of the MAPK kinase inhibitor
2amino-3-methoxyflavone (PD98059; 40 M; Fig. 6A). No
activation of the PI-3K pathway was observed (data not shown).
To investigate if MAPK activation was LTC4 receptor-medi-
ated, we performed the same experiment in the presence of a
cys-LT1 receptor antagonist (ICI 204.219). As shown in Figure
6B, the activation of MAPK over LPS/IFN--induced basal
level was inhibited by 1 M ICI 204.219. To demonstrate that
LTC4-induced PG increase was a result of an up-regulation of
COX-2, following the activation of the MAPK pathway, we
analyzed the COX-2 expression after 24 h activation of the
cells in the presence or absence of LTC4. As shown in Figure
7, we observed an increase two to three times over the LPS/
IFN--induced basal level, which corresponded to an increase
of PG levels.
DISCUSSION
We have found that in an in vitro model of inflammation, such
as TG-elicited mice peritoneal macrophages activated with
LPS/IFN-, the modulation of the 5-LO pathway, by gene
deletion or enzyme activity inhibition, corresponded to a par-
allel modulation of the COX pathway. However, it must be
pointed out that the modulation observed by 5-LO inhibition
was more pronounced with respect to what was produced by
5-LO gene deletion. This could be a result of compensatory
effects on other genes or other unknown actions of zileuton.
However, other mechanisms affecting the activation of the cells
cannot be ruled out. Thus, the suppression or inhibition of the
5-LO pathway in TG-elicited activated macrophages does not
result in an increase of PGE2 or 6-keto-PGF1 generation,
related to the shunting of the common substrate AA to the COX
pathway, as previously postulated in these cells but conversely,
results in an inhibition of the prostanoid biosynthesis. No
increase, but rather a decrease of PG biosynthesis following
5-LO inhibition, was also observed in the same cell type
following activation with LPS, according to Hubbard and
Erickson [10]; however, the results were neither explained nor
investigated further. Previous data by Feuerstein et al. [17]
showed that in elicited rat peritoneal macrophages, exogenous
LTC4 induced PG release in unstimulated cells with a similar
pattern with respect to LPS. However, the concentration of LPS
was not reported nor was the action of LTC4 on LPS activation.
We could not observe any action of exogenous LTC4 on PG
release from unstimulated cells. In contrast to what was re-
ported by Feuerstein et al. [17], our results show that the
engagement of the LPS pathway is needed for the increase of
PG biosynthesis induced by LT. Thus, the LPS “sensing ap-
paratus” seems to be crucial.
Fig. 4. Effect of exogenous LTC4 on PGE2 and
6-keto-PGF1 production by peritoneal macro-
phages from 5-LOWT and 5-LOKO mice after stim-
ulation with LPS and IFN-. Peritoneal macro-
phages were elicited by i.p. injection of 2 ml 4%
sterile TG medium. After 3 days, mice were killed,
and macrophages were harvested. Cells were plated
on 24-multi-well plates for 3 h, and nonadherent
cells were removed by washing with sterile PBS.
Immediately before the experiments, culture me-
dium was replaced by fresh medium without FBS to
avoid interference with RIA. The peritoneal mac-
rophages from 5-LOWT and 5-LOKO mice were
subsequently treated for 24 h with LPS (0.1 g/ml)
plus IFN- (10 U/ml) in the presence or absence of 1 M LTC4 and cys-LT1 receptor antagonist ICI 204.219 (1 M). PGE2 (A) and 6-keto-PGF1 (B) were
quantified in medium from cell incubation without prior extraction or purification by RIA. Data are expressed as means  SEM from three separate experiments
performed in triplicate. **, P  0.001; *, P  0.01, versus LPS/IFN- alone; , P  0.001, versus LPS/IFN- plus LTC4; #, P  0.01, versus LPS/IFN- plus LTC4.
Fig. 3. Effect of increasing concentration of exog-
enous LTC4 on PGE2 and 6-keto-PGF1 production
by peritoneal macrophages from 5-LOWT mice
stimulated with LPS/IFN-. Peritoneal macro-
phages were elicited by i.p. injection of 2 ml 4%
sterile TG medium. After 3 days, mice were killed,
and macrophages were harvested. Cells were plated
on 24-multi-well plates for 3 h, and nonadherent
cells were removed by washing with sterile PBS.
Immediately before the experiments, culture me-
dium was replaced by fresh medium without FBS to
avoid interference with RIA. Peritoneal macro-
phages were treated subsequently for 24 h with LPS
(0.1 g/ml) and IFN- (1 U/ml) in the presence of increasing concentration of LTC4 (0.001–1 M). Prostanoids were quantified in medium from cell incubation
without prior extraction or purification by RIA. Data are expressed as percent increase of prostanoid production with respect to control (LPS/IFN- only) in three
separate experiments performed in triplicate.
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The modulation of PG generation by 5-LO was specifically
dependent on LTC4, as LTD4, LTE4, and LTB4 were not active.
It must be pointed out that exogenously added LTC4 also
potentiated PG biosynthesis in stimulated macrophages from
Fig. 5. Effect of exogenous LTC4 on PGE2 and 6-keto-PGF1 production by
peritoneal macrophages from 5-LOWT mice after stimulation with increasing
concentration of LPS and IFN-. Peritoneal macrophages were elicited by i.p.
injection of 2 ml 4% sterile TG medium. After 3 days, mice were killed, and
macrophages were harvested. Cells were plated on 24-multi-well plates for 3 h, and
nonadherent cells were removed by washing with sterile PBS. Immediately before
the experiments, culture medium was replaced by fresh medium without FBS to
avoid interference with RIA. The peritoneal macrophages from 5-LOWT mice were
subsequently treated for 24 h with increasing concentration of LPS and IFN- in
the presence or absence of 1 M LTC4. PGE2 (A) and 6-keto-PGF1 (B) were
quantified in medium from cell incubation without prior extraction or purification
by RIA. Data are expressed as means  SEM from three separate experiments
performed in triplicate. **, P  0.001; *, P  0.01, versus LPS/IFN- alone.
Fig. 6. Effect of exogenous LTC4 on the activation of MAPK signal-transduction pathway in peritoneal macrophages from 5-LOWT mice stimulated with
LPS/IFN-. Peritoneal macrophages were elicited by i.p. injection of 2 ml 4% sterile TG medium. After 3 days, mice were killed, and macrophages were harvested.
Cells were plated on 24-multi-well plates for 3 h, and nonadherent cells were removed by washing with sterile PBS. Peritoneal macrophages were subsequently
treated for 24 h with LPS (0.1 g/ml) and IFN- (1 U/ml; A) in the presence or absence of the MAPK kinase (MEK) inhibitor PD98059 (40 M) and (B) in the
presence or absence of 1 M LTC4 and cys-LT1 receptor antagonist ICI 204.219 (1 M). After 24 h, the cells were lysed, and the proteins were separated by
SDS-PAGE and immunoblotted with an antibody specific for pERK-1/2 and ERK-2. The illustrated blots are representative of at least three separate experiments. Data
are expressed as means  SEM of three experiments for each group. *, P  0.001, versus control (LPS/IFN- only), and , P  0.001, versus LPS/IFN- plus LTC4.
Fig. 7. Effect of exogenous LTC4 on COX-2 expression in peritoneal macro-
phages from 5-LOWT mice stimulated with LPS/IFN-. Peritoneal macro-
phages were elicited by i.p. injection of 2 ml 4% sterile TG medium. After 3
days, mice were killed, and macrophages were harvested. Cells were plated on
24-multi-well plates for 3 h, and nonadherent cells were removed by washing
with sterile PBS. Peritoneal macrophages were subsequently treated for 24 h
with LPS (0.1 g/ml) and IFN- (1 U/ml) in the presence or absence of 1 M
LTC4. After 24 h, the cells were lysed, and the proteins were separated by
SDS-PAGE and immunoblotted with an antibody specific for COX-2 and
tubuline. The illustrated blots are representative of at least three separate
experiments. Data are expressed as means  SEM of three experiments for each
group. *, P  0.001, versus control (LPS/IFN- only).
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5-LOKO mice. It is interesting that in our experimental con-
ditions, the cells were able to release, after 18 and 24 h of
activation, only cys-LTs. This is in agreement with previous
data reported by Hubbard and Erickson [10]. Moreover, our
results show that inflammatory mediators display a certain
degree of specificity depending on cell types. This is in agree-
ment with what was shown in other cell types, such as intes-
tinal epithelial cells, where only LTB4 and LTD4 but not LTC4
positively modulate PG biosynthesis [18]. However, our results
do not exclude that other 5-LO products, such as 5-hydroper-
oxyeicosatetraenoic acid, 5-hydroxyeicosatetraenoic acid, or
eicosatetraenoic acid 5-oxo-6,8,11,14-HETE, could affect PG
generation. The LT-induced increase in PG generation, ob-
served in peritoneal macrophages, seems to be dependent by a
specific ligand-receptor interaction, as demonstrated by the
use of a cys-LT1 receptor antagonist (ICI 204.219), although
also, a direct action of the antagonist used on PG generation
cannot be excluded. Moreover, the finding that LTC4 was not
able to affect PG generation in unstimulated cells suggests that
this action could be specific for PG generated by COX-2. In
fact, as reported by Brock et al. [19], unstimulated peritoneal
macrophages produce PG from COX-1 activity, whereas PGE2
and PGI2 generation, following activation with LPS, depends
on COX-2 activity. An action on PGE-2 synthase can be
excluded, as the same results were obtained for 6-keto-PGF1.
Further support for this assumption is provided by the obser-
vation that the increased PG generation, induced by the cys-
LT, correlated with an up-regulation of COX-2 expression. This
is of particular interest, as COX-2 up-regulation is present in
different tumor types. The signal transduction mechanism in-
volved in this up-regulation is related to the activation of the
MAPK, a family of protein serine/threonine kinases, which
includes the ERK-1 and ERK-2 [20]. In particular, the MAPK
activation observed in our study is correlated with the phos-
phorilation of Erk-1/2 through the activation of the cys-LT1
receptor, as demonstrated by the use of the specific Mek
inhibitor PD98059 and the cys-LT1 receptor antagonist ICI
204.219, respectively. It is well known that among the multiple
signal pathways activated in macrophages upon LPS exposure,
there is the MAPK/ERK1/2. Thus, the potentiation by LTC4 of
LPS activity could also be related to a stimulation of this
signaling pathway. Further support for this hypothesis is the
LPS concentration dependence of the LTC4 action. In fact, we
showed that at a concentration of LPS, being a maximal stim-
ulus for PG production, the LTC4 did not produce any effect,
whereas at LPS concentration, giving a submaximal stimulus or
half-maximal stimulus, we observed a graduated response.
MAPK are involved in the regulation of cellular proliferation
[20]. Recently, it has been shown that in intestinal epithelial
cells and in colon cancer cells, LTD4 strongly increase COX-2
expression thorough the cys-LT1 receptor via the MAPK Erk-
1/2 pathway [21, 22]. Thus, in these cell types, cys-LTs seem
to promote cell proliferation through the up-regulation of
COX-2 via the MAPK Erk-1/2 pathway. It is interesting to note
that in a tumor type, such as colorectal adenocarcinomas, there
are high levels of cys-LT1 receptor and COX-2 [23]. Moreover,
some studies have shown that increased COX-2 expression in
colon cancer originates mainly from interstitial cells (i.e., mac-
rophages), whereas little COX-2 expression was found in epi-
thelial cancer cells [24]. As described for COX-2, 5-LO also
seems to participate in the regulation of cell proliferation, and
5-LO is expressed by a broad variety of cancer cells [25]. In
light of our and other findings [20, 23, 24], it is evident that
there is a mutual interaction between the COX and 5-LO
pathways. In fact, if 5-LO positively modulates the COX path-
way, PG, especially PGE2, via its EP4 receptor, negatively
regulates 5-LO translocation and activation through a complex
series of events [19]. As COX-2 and 5-LO seem to have
redundant functions, the balance between COX and 5-LO
metabolites seems to be of great importance in controlling
macrophage functions, inflammation, and tumor promotion.
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